Overview
Hazard
analysis has always played an important role in medical device safety. Under
FDA’s Quality Management System Regulation, risk information now carries wider
significance across the quality system and can influence decisions involving
suppliers, validation, complaints, CAPA, change control, and postmarket
surveillance.
Medical
device companies must be able to show more than a completed risk table. They
need a clear and consistent process for identifying hazards, evaluating
potential harm, selecting appropriate controls, documenting risk decisions, and
using new quality and postmarket information to keep those decisions current.
Several
techniques can be used to evaluate risk, including Failure Modes and Effects
Analysis, Fault Tree Analysis, and Hazard Analysis. Hazard Analysis, as
described in ISO 14971, provides a comprehensive way to examine risks arising
during normal operation, fault conditions, and reasonably foreseeable misuse.
However, terms such as “hazard,” “hazardous situation,” “harm,” “risk
acceptability,” and “residual risk” are frequently misunderstood or applied
inconsistently.
This
practical webinar will explain the hazard-analysis process in clear, usable
language. Attendees will be guided step by step through a hazard-analysis
template, with examples showing how hazards develop into hazardous situations
and potential harm, how risks are evaluated, and how appropriate controls are
selected.
The
program will also demonstrate how hazard analysis applies beyond product
design. Attendees will learn how risk information should support supplier
controls, validation activities, complaint and CAPA decisions, change
assessments, and postmarket surveillance under the current QMSR environment.
Templates
and step-by-step examples will be provided to help participants apply the
concepts within their own quality systems and build risk decisions that are
clear, consistent, traceable, and ready for regulatory review.
Areas
covered in the session:
- Risk
analysis requirements that are described in the QMSR
- explanation
of Hazard Analysis terms: hazard, hazardous situation, harm, risk,
acceptability criteria, benefit/ risk ratio
- explanation
of the hazard analysis process using a template
- examples
of terms will be given
- Application
of risk management to Quality System processes will be explained
- hazard
analysis examples will be covered step by step
To
support implementation of the concepts discussed during the webinar, attendees
will receive the following handouts:
- Medical
Device Hazard Analysis Builder and Worked Example
- QMSR
Hazard Analysis Application and Update Decision Guide
Why should you attend?
Hazard
Analysis is one of the most effective tools for identifying and controlling
medical device risk, yet terms such as hazard, hazardous situation, harm,
acceptability criteria, and benefit-risk are often misunderstood. This webinar
will break down these concepts using clear explanations, practical examples,
and a step-by-step template.
You
will learn how Hazard Analysis applies beyond product design and supports
important quality system decisions involving supplier controls, validation,
complaints, CAPA, change control, and postmarket surveillance under the QMSR
environment.
By
attending, you will gain a practical framework for evaluating risk, documenting
defensible decisions, and applying Hazard Analysis consistently across your
quality processes. Templates and worked examples will help you put the concepts
into use within your own organization.
Who
Will Benefit?
This
webinar is designed for medical device professionals responsible for
identifying, evaluating, controlling, documenting, or reviewing product and
quality-system risks. It will be especially valuable to those involved in
supplier controls, validation, complaints, CAPA, change control, and postmarket
surveillance; those include:
- Quality
Assurance Managers
- Quality
Systems Managers
- Regulatory
Affairs Managers
- Risk
Management Professionals
- Design
Assurance Engineers
- Design
and Development Engineers
- Research
and Development Managers
- Medical
Device Engineers
- Systems
Engineers
- Software
Quality Engineers
- Software
Validation Professionals
- Human
Factors and Usability Professionals
- Validation
Managers and Engineers
- Supplier
Quality Managers and Engineers
- Manufacturing
Quality Managers
- Process
Validation Engineers
- Complaint
Handling Managers and Specialists
- CAPA
Managers and Investigators
- Postmarket
Surveillance Professionals
- Product
Safety Professionals
- Clinical
Affairs Professionals
- Internal
Auditors
- Quality
Compliance Specialists
- Regulatory
Compliance Consultants
- Directors
and Vice Presidents of Quality
- Directors and Vice Presidents of Regulatory Affairs
Edwin Waldbusser is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the US and internationally in the areas of design control, risk analysis and software validation for the past 11 years.
Mr. Waldbusser has a BS in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 Lead Auditor and a member of the Thomson Reuters Expert Witness network.
Enrollment Options
Tags: Hazard Analysis, FDA QMSR, ISO 14971, Medical Device Risk Management, Risk Analysis, Quality Systems, Supplier Controls, Validation, Complaints, CAPA, Change Control, Postmarket Surveillance, FDA Compliance, Medical Device Training, Risk Assessment, edwin waldbusser, august 2026, webinar

